Callisto Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 15-07-2024
- Paid Up Capital ₹ 1.00 M
as on 15-07-2024
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 168.05%
(FY 2022)
- Profit 44.59%
(FY 2022)
- Ebitda 44.39%
(FY 2022)
- Net Worth -16.66%
(FY 2022)
- Total Assets 3.87%
(FY 2022)
About Callisto Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Raghav Thakur, Roshan Choudhary, and Sudhanshu Chaudhary serve as directors at the Company.
- CIN/LLPIN
U24304JH2017PLC022602
- Company No.
169755
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
05 Apr 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jharkhand
Industry
Company Details
- Location
Pune City, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Callisto Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raghav Thakur  | Director | 16-Oct-2017 | Current |
| Roshan Choudhary | Director | 07-Aug-2019 | Current |
| Sudhanshu Chaudhary | Director | 20-Dec-2022 | Current |
Financial Performance of Callisto Laboratories.
Callisto Laboratories Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 168.05% increase. The company also saw a substantial improvement in profitability, with a 44.59% increase in profit. The company's net worth observed a substantial decline by a decrease of 16.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Callisto Laboratories?
In 2022, Callisto Laboratories had a promoter holding of 99.60% and a public holding of 0.40%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Callisto Laboratories?
Callisto Laboratories has a workforce of 36 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Callisto Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Callisto Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
